STOCKWATCH
·
Major Chemicals
Quarterly ResultMay 6, 2026, 04:26 PM

Albemarle Q1 Net Sales $1.4B (+33%); Adjusted EBITDA $664M (+148%)

AI Summary

Albemarle Corporation reported strong first-quarter 2026 results, with net sales increasing 33% year-over-year to $1.4 billion and adjusted EBITDA surging 148% to $664 million. The growth was primarily driven by higher pricing and volumes in its Energy Storage and Specialties segments, alongside ongoing cost and productivity improvements. The company also strengthened its balance sheet by paying down $1.3 billion in debt and completed divestments of Eurecat and Ketjen for $648 million in net cash proceeds. Albemarle improved its 2026 outlook for Specialties and reduced interest expense, though the overall enterprise outlook remains stable due to offsetting supply chain disruptions.

Key Highlights

  • Net sales rose 33% year-over-year to $1.4 billion.
  • Adjusted EBITDA increased 148% to $664 million.
  • Net income was $319 million, or $2.34 per diluted share.
  • Energy Storage net sales grew 70% to $891 million; Adjusted EBITDA up 196% to $551 million.
  • Specialties net sales increased 12% to $358 million; Adjusted EBITDA up 30% to $76 million.
  • Paid down $1.3 billion of outstanding debt, reducing interest rates.
  • Generated $346 million in cash from operating activities and $248 million in free cash flow.
  • Closed divestments of Eurecat and Ketjen for $648 million net cash proceeds.
ALB
Major Chemicals
ALBEMARLE CORP

Price Impact